vs

Side-by-side financial comparison of Almonty Industries Inc. (ALM) and cbdMD, Inc. (YCBD). Click either name above to swap in a different company.

Almonty Industries Inc. is the larger business by last-quarter revenue ($6.3M vs $5.0M, roughly 1.3× cbdMD, Inc.). cbdMD, Inc. runs the higher net margin — -5.6% vs -86.1%, a 80.4% gap on every dollar of revenue.

Almonty Industries Inc. is an international mining company primarily engaged in the extraction and development of tungsten resources. The company operates in Spain, Portugal, and South Korea and is publicly traded on the Toronto Stock Exchange (TSX). The current Chief Executive Officer is Lewis Black.

cbdMD, Inc. is a U.S.-based consumer wellness company that manufactures and distributes hemp-derived CBD products, including tinctures, topicals, gummies, pet care items, and bath products. All offerings undergo third-party quality testing, and are sold via e-commerce platforms, brick-and-mortar retail stores, and wellness partner channels primarily across the United States.

ALM vs YCBD — Head-to-Head

Bigger by revenue
ALM
ALM
1.3× larger
ALM
$6.3M
$5.0M
YCBD
Higher net margin
YCBD
YCBD
80.4% more per $
YCBD
-5.6%
-86.1%
ALM

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
ALM
ALM
YCBD
YCBD
Revenue
$6.3M
$5.0M
Net Profit
$-5.4M
$-283.1K
Gross Margin
59.8%
Operating Margin
-5.7%
Net Margin
-86.1%
-5.6%
Revenue YoY
-1.9%
Net Profit YoY
-1975.7%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALM
ALM
YCBD
YCBD
Q4 25
$5.0M
Q3 25
$6.3M
$4.7M
Q2 25
$7.2M
$4.6M
Q1 25
$4.7M
Q4 24
$5.1M
Q3 24
$4.6M
Q2 24
$5.2M
Q1 24
$4.4M
Net Profit
ALM
ALM
YCBD
YCBD
Q4 25
$-283.1K
Q3 25
$-5.4M
$-680.0K
Q2 25
$-58.2M
$-895.3K
Q1 25
$-480.8K
Q4 24
$15.1K
Q3 24
$-152.8K
Q2 24
$459.7K
Q1 24
$-3.0M
Gross Margin
ALM
ALM
YCBD
YCBD
Q4 25
59.8%
Q3 25
58.8%
Q2 25
61.5%
Q1 25
62.3%
Q4 24
66.5%
Q3 24
53.9%
Q2 24
65.8%
Q1 24
59.0%
Operating Margin
ALM
ALM
YCBD
YCBD
Q4 25
-5.7%
Q3 25
-14.5%
Q2 25
-19.6%
Q1 25
-10.2%
Q4 24
-1.7%
Q3 24
-6.9%
Q2 24
-7.4%
Q1 24
-35.4%
Net Margin
ALM
ALM
YCBD
YCBD
Q4 25
-5.6%
Q3 25
-86.1%
-14.4%
Q2 25
-809.4%
-19.4%
Q1 25
-10.1%
Q4 24
0.3%
Q3 24
-3.4%
Q2 24
8.9%
Q1 24
-68.8%
EPS (diluted)
ALM
ALM
YCBD
YCBD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$-0.15
Q1 24
$-1.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALM
ALM
YCBD
YCBD
Cash + ST InvestmentsLiquidity on hand
$3.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$9.0M
Total Assets
$11.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALM
ALM
YCBD
YCBD
Q4 25
$3.4M
Q3 25
$2.3M
Q2 25
$1.1M
Q1 25
$1.8M
Q4 24
$2.0M
Q3 24
$2.5M
Q2 24
$2.4M
Q1 24
$2.1M
Stockholders' Equity
ALM
ALM
YCBD
YCBD
Q4 25
$9.0M
Q3 25
$7.2M
Q2 25
$6.1M
Q1 25
$665.8K
Q4 24
$1.8M
Q3 24
$2.0M
Q2 24
$3.0M
Q1 24
$3.1M
Total Assets
ALM
ALM
YCBD
YCBD
Q4 25
$11.8M
Q3 25
$10.4M
Q2 25
$9.9M
Q1 25
$10.9M
Q4 24
$11.5M
Q3 24
$10.6M
Q2 24
$13.8M
Q1 24
$14.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALM
ALM
YCBD
YCBD
Operating Cash FlowLast quarter
$-812.5K
Free Cash FlowOCF − Capex
$-977.3K
FCF MarginFCF / Revenue
-19.5%
Capex IntensityCapex / Revenue
3.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALM
ALM
YCBD
YCBD
Q4 25
$-812.5K
Q3 25
$-240.7K
Q2 25
$-704.2K
Q1 25
$-189.5K
Q4 24
$-317.9K
Q3 24
$167.4K
Q2 24
$289.8K
Q1 24
$-704.1K
Free Cash Flow
ALM
ALM
YCBD
YCBD
Q4 25
$-977.3K
Q3 25
$-243.6K
Q2 25
$-705.7K
Q1 25
$-205.0K
Q4 24
$-482.3K
Q3 24
$157.4K
Q2 24
Q1 24
$-708.7K
FCF Margin
ALM
ALM
YCBD
YCBD
Q4 25
-19.5%
Q3 25
-5.2%
Q2 25
-15.3%
Q1 25
-4.3%
Q4 24
-9.4%
Q3 24
3.5%
Q2 24
Q1 24
-16.2%
Capex Intensity
ALM
ALM
YCBD
YCBD
Q4 25
3.3%
Q3 25
0.1%
Q2 25
0.0%
Q1 25
0.3%
Q4 24
3.2%
Q3 24
0.2%
Q2 24
0.0%
Q1 24
0.1%
Cash Conversion
ALM
ALM
YCBD
YCBD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-21.06×
Q3 24
Q2 24
0.63×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALM
ALM

Segment breakdown not available.

YCBD
YCBD

Sales Channel Directly To Consumer$3.6M72%
Sales Channel Through Intermediary$1.4M28%

Related Comparisons